E. coli; drug repositioning; drug targets; gene regulation; inflammation; mastitis; Animal Science and Zoology; Veterinary (all); General Veterinary
Abstract :
[en] Mastitis, a disease with high incidence worldwide, is the most prevalent and costly disease in the dairy industry. Gram-negative bacteria such as Escherichia coli (E. coli) are assumed to be among the leading agents causing acute severe infection with clinical signs. E. Coli, environmental mastitis pathogens, are the primary etiological agents of bovine mastitis in well-managed dairy farms. Response to E. Coli infection has a complex pattern affected by genetic and environmental parameters. On the other hand, the efficacy of antibiotics and/or anti-inflammatory treatment in E. coli mastitis is still a topic of scientific debate, and studies on the treatment of clinical cases show conflicting results. Unraveling the bio-signature of mastitis in dairy cattle can open new avenues for drug repurposing. In the current research, a novel, semi-supervised heterogeneous label propagation algorithm named Heter-LP, which applies both local and global network features for data integration, was used to potentially identify novel therapeutic avenues for the treatment of E. coli mastitis. Online data repositories relevant to known diseases, drugs, and gene targets, along with other specialized biological information for E. coli mastitis, including critical genes with robust bio-signatures, drugs, and related disorders, were used as input data for analysis with the Heter-LP algorithm. Our research identified novel drugs such as Glibenclamide, Ipratropium, Salbutamol, and Carbidopa as possible therapeutics that could be used against E. coli mastitis. Predicted relationships can be used by pharmaceutical scientists or veterinarians to find commercially efficacious medicines or a combination of two or more active compounds to treat this infectious disease.
Disciplines :
Animal production & animal husbandry
Author, co-author :
Sharifi, Somayeh ; Department of Animal Sciences, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran ; Department of Animal Science, Iowa State University, Ames, IA 50011, USA
Lotfi Shahreza, Maryam ; Department of Computer Engineering, Shahreza Campus, University of Isfahan, Isfahan 86149-56841, Iran
Pakdel, Abbas; Department of Animal Sciences, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran
Reecy, James M; Department of Animal Science, Iowa State University, Ames, IA 50011, USA
Ghadiri, Nasser ; Department of Electrical and Computer Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran
Atashi, Hadi ; Université de Liège - ULiège > Département GxABT > Animal Sciences (AS) ; Department of Animal Science, Shiraz University, Shiraz 71946-84334, Iran
Motamedi, Mahmood; Department of Animal Sciences, University of Tehran, Tehran 1417935840, Iran
Ebrahimie, Esmaeil ; Genomics Research Platform, School of Life Sciences, College of Science, Health and Engineering, La Trobe University, Melbourne, VIC 3086, Australia ; School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, SA 5371, Australia ; School of BioSciences, The University of Melbourne, Melbourne, VIC 3010, Australia
Language :
English
Title :
Systems Biology-Derived Genetic Signatures of Mastitis in Dairy Cattle: A New Avenue for Drug Repurposing.
Rollin, E.; Dhuyvetter, K.C.; Overton, M.W. The cost of clinical mastitis in the first 30 days of lactation: An economic modeling tool. Prev. Vet. Med. 2015, 122, 257–264. https://doi.org/10.1016/j.prevetmed.2015.11.006.
Bar, D.; Tauer, L.W.; Bennett, G.; González, R.N.; Hertl, J.A.; Schukken, Y.H.; Schulte, H.F.; Welcome, F.L.; Gröhn, Y.T. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. J. Dairy Sci. 2008, 91, 2205–2214. https://doi.org/10.3168/jds.2007-0573.
Sharifi, S.; Pakdel, A. Bovine Mastitis: Etiology and Epidemiology, challenges, current trends and future perspectives in monitoring, detection and treatment. Mastitis Symptoms, Triggers and Treatment; NOVA: New York, NY, USA, 2019; ISBN 978-1-53616-124-3.
Bradley, A. Bovine mastitis: An evolving disease. Vet. J. 2002, 164, 116–128.
Hogan, J., Larry Smith, K. Coliform mastitis. Vet. Res. 2003, 34, 507–519. https://doi.org/10.1051/vetres:2003022.
Zadoks, R., Fitzpatrick, J. Changing trends in mastitis. Ir. Vet. J. 2009, 62 (Suppl. 4), S59–S70. https://doi.org/10.1186/2046-0481-62-S4-S59.
Viguier, C.; Arora, S.; Gilmartin, N.; Welbeck, K.; O’Kennedy, R. Mastitis detection: Current trends and future perspectives. Trends Biotechnol. 2009, 27, 486–493. https://doi.org/10.1016/j.tibtech.2009.05.004.
Lewis, J.D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011, 140, 1817–1826. https://doi.org/10.1053/j.gastro.2010.11.058.
Sharifi, S.; Pakdel, A.; Ebrahimi, M.; Reecy, J.M.; Fazeli Farsani, S.; Ebrahimie, E. Integration of machine learning and metaanalysis identifies the transcriptomic bio-signature of mastitis disease in cattle. PLoS ONE 2018, 13, e0191227. https://doi.org/10.1371/journal.pone.0191227.
Tiwari, J.G.; Babra, C.; Tiwari, H.K.; Williams, V.; Wet, S.D.; Gibson, J.; Paxman, A.; Morgan, E.; Costantino, P.; Sunagar, R.; et al. Trends In Therapeutic and Prevention Strategies for Management of Bovine Mastitis: An Overview. J. Vaccines Vaccin. 2013, 4, 1–11.
Gomes, F.; Henriques, M. Control of Bovine Mastitis: Old and Recent Therapeutic Approaches. Curr. Microbiol. 2016, 72, 377– 382. https://doi.org/10.1007/s00284-015-0958-8.
Camerlink, I.; Ellinger, L.; Bakker, E.J.; Lantinga, E.A. Homeopathy as replacement to antibiotics in the case of Escherichia coli diarrhoea in neonatal piglets. Homeopathy 2010, 99, 57–62.
Lehtolainen, T,.; Shwimmer, A.; Shpigel, N.Y.; Honkanen-Buzalski, T.; Pyorala S. In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel. J. Dairy Sci. 2003, 86, 3927–3932.
Lotfi Shahreza M, Ghadiri N, Mousavi SR, Varshosaz, J., Green JR. A review of network-based approaches to drug repositioning. Brief Bioinform. 2018, 19, 878–892. https://doi.org/10.1093/bib/bbx017.
Lotfi, S.M.; Ghadiri, N.; Green, J.R. A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma. Sci. Rep. 2020, 10, 8846. https://doi.org/10.1038/s41598-020-65658-x.
Lotfi, S.M.; Ghadiri, N.; Mousavi, S.R.; Varshosaz, J.; Green, J.R. Heter-LP: A heterogeneous label propagation algorithm and its application in drug repositioning. J. Biomed. Inform. 2017, 68, 167–183. https://doi.org/10.1016/j.jbi.2017.03.006.
Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.; Dwight, S.S.; Eppig, J.T.; et al., ht tp: //www.geneontology.org, Gene ontology. Tool for the unification of biology. Gene. Ontol. Consort. 2000, 25, 25–29.
Nikitin, A.; Egorov, S.; Daraselia, N.; Mazo, I. Pathway studio--the analysis and navigation of molecular networks. Bioinformatics 2003, 19, 2155–2157.
Sharifi, S.; Pakdel, A.; Ebrahimie, E.; Aryan, Y.; Reecy, J.M. Prediction of key regulators and downstream targets of E. coli induced mastitis. J. Appl. Genetics. 2019, 60, 367–373, https://doi.org/10.1007/s13353-019-00499-7.
Li, L.; Chen, X.; Chen, Z. Identification of Key Candidate Genes in Dairy Cow in Response to Escherichia coli Mastitis by Bioinformatical Analysis. Front. Genet. 2019, 10, 1251.
Younis, S.; Javed, Q.; Blumenberg,M. Meta-Analysis of Transcriptional Responses to Mastitis-Causing Escherichia coli. PLoS ONE 2016, 11, e0148562.
Wagner, S.A. The Effects of anti-Infammatory Drugs on Clinical Signs, Milk Production, and Mammary Epithelial Cells in Cows with Endotoxin-Induced Mastitis, PhD thesis, Iowa State University, Ames, IA, USA, 2003.
Oliver, S.P.; Murinda, S.E.; Jayarao, B.M. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: A comprehensive review. Foodborne Pathog. Dis. 2011, 8, 337–355.
Oliver, S.P. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis. Vet. Microbiol. 2007, 124, 319–328. https://doi.org/10.1016/j.vetmic.2007.04.040.
Lohuis, J.A.; Van Leeuwen, W.; Verheijden, J.H.; Van Miert, A.S.; Brand, A. Effect of dexamethasone on experimental Escherichia coli mastitis in the cow. J. Dairy Sci. 1988, 71, 2782–2789.
Wagner, S.A.; Apley, M.D. Effects of two anti-inflammatory drugs on physiologic variables and milk production in cows with endotoxin-induced mastitis. Am. J. Vet. Res. 2004, 65, 64–68.
McDougall, S., Bryan MA, Tiddy RM. Effect of treatment with the nonsteroidal anti-inflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. J. Dairy Sci. 2009, 92, 4421–4431. https://doi.org/10.3168/jds.2009-2284.
Olson, M.E.; Ceri, H.; Morck, D.W.; Buret, A.G.; Read, R.R. Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can. J. Vet. Res. 2002, 66, 86–92.
Ziv, G.; Shem-Tov, M.; Ascher, F. Combined effect of ampicillin, colistin and dexamethasone administered intramuscularly to dairy cows on the clinico-pathological course of E. coli-endotoxin mastitis. Vet. Res. 1998, 29, 89–98.
Barlow, J. Mastitis therapy and antimicrobial susceptibility: A multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle. J. Mamar. Gland Biol. Neoplasia 2011, 16, 383–407.
Ebrahimi, M.; Mohammadi-Dehcheshmeh, M.; Ebrahimie, E.; Petrovski, K.R. Comprehensive analysis of machine learning models for prediction of sub-clinical mastitis: Deep Learning and Gradient-Boosted Trees outperform other models. Comput. Biol. Med. 2019, 114, 103456. https://doi.org/https://doi.org/10.1016/j.compbiomed.2019.103456.
Ebrahimie, E.; Ebrahimi, F.; Ebrahimi, M.; Tomlinson, S.; Petrovski, K.R. A large-scale study of indicators of sub-clinical mastitis in dairy cattle by attribute weighting analysis of milk composition features: Highlighting the predictive power of lactose and electrical conductivity. J. Dairy Res. 2018, 85, 193–200. https://doi.org/10.1017/S0022029918000249.
Jamali, A.A.; Ferdousi, R.; Razzaghi, S.; Li, J.; Safdari, R.; Ebrahimie, E. DrugMiner: Comparative analysis of machine learning algorithms for prediction of potential druggable proteins. Drug Discov. Today 2016, 21, 718–724.
KayvanJoo, A.H.; Ebrahimi, M.; Haqshenas, G. Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms. BMC Res. Notes 2014, 7, 1–11. https://doi.org/10.1186/1756-0500-7-565.
Farouk, O.; Abdelkhalek, M.; Abdallah, A.; Shata, A.; Senbel, A.; Attia, E.; Elghaffar, M.A.; Mesbah, M.; Soliman, N.; Amin, M.; et al. Rifampicin for Idiopathic Granulomatous Lobular Mastitis: A Promising Alternative for Treatment. World J. Surg. 2017, 41, 1313–1321.
Miller, S.I. Antibiotic Resistance and Regulation of the Gram-Negative Bacterial Outer Membrane Barrier by Host Innate Immune Molecules. MBio 2016, 7, e01541–e16. https://doi.org/10.1128/mBio.01541-16.
Erskine, R.J.; Walker, R.D.; Bolin, C.A.; Bartlett, P.C.; White, D.G. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 2002, 85, 1111–1118.
Simard, J.M.; Geng, Z.; Woo, S.K.; Ivanova, S.; Tosun, C.; Melnichenko, L.; Gerzanich, V. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2009, 29, 317–330.
Zhang, W.; Fievez, L.; Cheu, E.; Bureau, F.; Rong, W.; Zhang, F.; Zhang, Y.; Advenier, C.; Gustin, P. Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. Eur. J Pharmacol. 2010, 628, 171–178.
Kvetny, J.; Heldgaard, P.E.; Bladbjerg, E.M.; Gram, J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin. Endocrinol. 2004, 61, 232–238.
Abbas, A.M.; Sakr, H.F. Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism. Can. J. Physiol. Pharmacol. 2016, 94, 426–432.
Uzkeser, H.; Cadirci, E.; Halici, Z.; Odabasoglu, F.; Polat, B.; Yuksel, T.N.; Ozaltin, S.; Atalay, F. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: Involvement of an antioxidant mechanism. Mediat. Inflamm. 2012, 2012, 438912.
Zhu, H.; Lemos, H.; Bhatt, B.; Islam, B.N.; Singh, A.; Gurav, A.; Huang, L.; Browning, D.D.; Mellor, A.; Fulzele, S.; Singh, N. Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity. PLoS ONE 2017, 12, e0183484.
